This is the authors' abstract. We don't add key points for this paper.
Arthrospira platensisis a cyanobacterium known for its widespread use as nutraceutical and food additive. Besides a high protein content, this microorganism is also endowed with several bioactivities related to health benefits in humans that make it a candidate for functional foods. These properties are strain and culture condition dependent. We compared, in terms of biomass productivity and protein, C-phycocyanin, and polysaccharide content, twoA. platensisstrains,A. platensisF&M-C256 andA. platensisF&M-C260, characterized by morphological differences. The organisms were grown in annular photobioreactors with light-emitting diodes (LED) as light source in fed-batch and semi-continuous regimes. No significant differences in biomass productivity were found between the two strains. Both strains showed a protein content >55% in all culture conditions. C-phycocyanin content was higher inA. platensisF&M-C260 in semi-continuous regime. Cellular polysaccharide (PS) content, which included intracellular polysaccharide and those bound to the cell wall, was higher inA. platensisF&M-C256 during semi-continuous cultivation. In both strains, a higher release of polysaccharide was observed at the end of the fed-batch regime.A. platensisF&M-C256 showed the advantage to form clumps which facilitate harvesting, behavior not observed inA. platensisF&M-C260 and probably related to the different predominant monosaccharide found in the PS of the two strains (i.e., rhamnose inA. platensisF&M-C256 and glucose inA. platensisF&M-C260). The results show that the two strains are suitable for commercial production of high-value products, such as protein and C-phycocyanin, while for polysaccharide production,A. platensisF&M-C256 is preferable.
No takes yet. Share an insight, caveat, or question.
Zanolla et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: